Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency.
暂无分享,去创建一个
A. Catizone | M. Carbonari | M. Fiorilli | I. Quinti | M. Visentini | M. Mitrevski | C. Lazzeri | Ramona Marrapodi | A. Camponeschi | Valentina Conti
[1] M. Sztein,et al. Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level , 2012, Front. Cell. Inf. Microbio..
[2] G. Russo,et al. Clonal B cells of HCV‐associated mixed cryoglobulinemia patients contain exhausted marginal zone‐like and CD21low cells overexpressing Stra13 , 2012, European journal of immunology.
[3] C. Cunningham-Rundles. Human B cell defects in perspective , 2012, Immunologic Research.
[4] A. Sette,et al. Antigen-Specific Acquired Immunity in Human Brucellosis: Implications for Diagnosis, Prognosis, and Vaccine Development , 2012, Front. Cell. Inf. Microbio..
[5] C. Cunningham-Rundles,et al. TLR-Mediated B Cell Defects and IFN-α in Common Variable Immunodeficiency , 2012, Journal of Clinical Immunology.
[6] M. Boes,et al. Defective calcium signaling and disrupted CD20-B-cell receptor dissociation in patients with common variable immunodeficiency disorders. , 2012, The Journal of allergy and clinical immunology.
[7] G. Ricci,et al. Hepatocyte growth factor (HGF) regulates blood–testis barrier (BTB) in adult rats , 2012, Molecular and Cellular Endocrinology.
[8] M. Waisberg,et al. Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments , 2011, Nature Immunology.
[9] K. Warnatz,et al. Telomere‐dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency , 2011, European journal of immunology.
[10] H. Eibel,et al. Common variable immunodeficiency at the end of a prospering decade: towards novel gene defects and beyond , 2010, Current opinion in allergy and clinical immunology.
[11] S. Hillion,et al. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. , 2010, Blood.
[12] C. Cunningham-Rundles,et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. , 2010, Blood.
[13] S. Feske,et al. B Cell Receptor-Mediated Calcium Signaling Is Impaired in B Lymphocytes of Type Ia Patients with Common Variable Immunodeficiency , 2010, The Journal of Immunology.
[14] T. Rothstein,et al. Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. , 2009, Molecular immunology.
[15] K. Schwarz,et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells , 2009, Proceedings of the National Academy of Sciences.
[16] K. Coggeshall,et al. B Cell Antigen Receptor Endocytosis and Antigen Presentation to T Cells Require Vav and Dynamin , 2009, The Journal of Biological Chemistry.
[17] J. Cambier,et al. Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells , 2009, Proceedings of the National Academy of Sciences.
[18] M. Polyak,et al. CD20 Homo-oligomers Physically Associate with the B Cell Antigen Receptor , 2008, Journal of Biological Chemistry.
[19] V. Boussiotis,et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. , 2008, Blood.
[20] S. Gauld,et al. B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.
[21] G. Packham,et al. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. , 2007, Blood.
[22] L. Miosge,et al. Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-κB in B cell clonal anergy , 2006, The Journal of experimental medicine.
[23] S. Gauld,et al. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling , 2005, Nature Immunology.
[24] Kunio Kondoh,et al. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity , 2005, Journal of Cell Science.
[25] M. D’Elios,et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. , 2005, Blood.
[26] A. Plebani,et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. , 2005, The Journal of allergy and clinical immunology.
[27] R. Harrison,et al. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton , 2004, Journal of Cell Science.
[28] C. Goodnow,et al. Resistance to CpG DNA–induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling , 2003, Nature Immunology.
[29] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[30] J. Pers,et al. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. , 2014, The Journal of allergy and clinical immunology.
[31] M. Boes,et al. B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutations. , 2011, Critical reviews in immunology.
[32] Eren,et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.
[33] T. Manser,et al. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. , 2001, Immunity.